The United States on Wednesday authorized Pfizer Inc’s antiviral COVID-19 pill for people ages 12 and older at risk of severe illness, the first oral and at-home treatment as well as a new tool against the fast-spreading Omicron variant. Read More
Advertisements
Daily Digest Signup
Daily business and market business news, business management tips, market research insights, and more.
Advertisements
